10-year experience in the use of Intravenous Immunoglobulin for Autoimmune Retinopathy. [PDF]
Abraham AR +9 more
europepmc +1 more source
ABSTRACT We here describe mouse models with complementary homozygous Svil mutations. In skeletal muscle, Svil‐Mut mice express the Svil‐encoded N‐terminus fused to the βgal‐neo gene‐trap tag and lack the highly conserved archvillin C‐terminus; Svil‐KO mice lack expression of all known Svil‐encoded proteins; and Svil‐LoxP mice contain loxP sites for ...
Tara C. Smith +9 more
wiley +1 more source
Intravenous Immunoglobulin Induces Sustained Hemostatic Responses in IgM Paraprotein-Associated Acquired Von Willebrand Syndrome. [PDF]
Alishah M, Imdad S, Jaffri M, Eisner R.
europepmc +1 more source
Effect of high-doses intravenous immunoglobulin in rheumatoid arthritis
LUCHETTI, MICHELE MARIA +4 more
core
Opsoclonus in Pediatric Patients: Differential Diagnosis and a Practical Approach to Evaluation
ABSTRACT Opsoclonus is an ocular dyskinesia characterized by involuntary, arrhythmic, multidirectional saccades. In pediatrics, opsoclonus is most commonly attributed to the rare neuroinflammatory disorder opsoclonus‐myoclonus‐ataxia syndrome (OMAS), typically considered a paraneoplastic syndrome associated with neural crest tumors. However, opsoclonus
Aubrey C. Reed +5 more
wiley +1 more source
Comment on the "Use of intravenous immunoglobulin for the treatment of severe COVID-19". [PDF]
Aaungsupawong H, Wiwanitkit V.
europepmc +1 more source
Circulating monocyte partitioning and its alteration in hematological chronic neoplasms
Abstract Circulating monocyte partitioning refers to the relative quantification of the three main monocyte subsets in the peripheral blood, namely classical (cMo), intermediate (iMo), and non‐classical (ncMo) monocytes, as assessed by flow cytometry, a new nomenclature described 15 years ago.
Sihem Tarfi +4 more
wiley +1 more source
Design of the MERCURION-IPF trial - intravenous immunoglobulin for the treatment of acute exacerbations of idiopathic pulmonary fibrosis. [PDF]
Sotiropoulou V +15 more
europepmc +1 more source
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler +4 more
wiley +1 more source
Association of Intravenous Immunoglobulin Therapy With Healthcare Utilization in Immunodeficient Adults With Chronic Rhinosinusitis. [PDF]
Figueroa M, Gao J, Tian CJ, Hur K.
europepmc +1 more source

